Target intelligence / Profile preview

Leukocidin S subunit of Panton–Valentine leukocidin (LukS-PV)

Target
LukS-PV
Molecular classification
Toxin, Bi-component pore-forming toxin, Bacterial exotoxin, Synergohymenotropic toxin family
01

Overview

The Leukocidin S subunit of Panton–Valentine leukocidin (LukS-PV) is one component of the two-part PVL toxin secreted by *Staphylococcus aureus*. PVL functions as a bi-component exotoxin composed of LukS-PV (S component) and LukF-PV (F component), which together form octameric β-barrel pores in the membranes of immune cells such as neutrophils and macrophages. LukS-PV binds first to specific host cell receptors, enabling LukF-PV to join, resulting in pore formation and rapid cell lysis. This mechanism is a major virulence factor in severe *S. aureus* infections, including community-acquired MRSA, skin abscesses, and necrotizing pneumonia. The gene encoding LukS-PV is located on lysogenic bacteriophages in *S. aureus*, and its presence is associated with increased bacterial virulence and poor clinical outcomes.

Other names
LukS-PVPVL S subunitPanton–Valentine leukocidin S componentStaphylococcal leukocidin S componentPVL-S
02

Mechanism of action

The LukS-PV binds first to specific receptors on the host immune cell surface, enables recruitment of the F component (LukF-PV), then together assemble into an oligomeric pore that disrupts cell membranes, causing lysis

03

Biological functions

Pore formation in host cell membranesCell lysis (specifically neutrophils, monocytes, macrophages)Immune evasionProinflammatory response induction
04

Disease associations

Infection (notably skin and soft tissue infections, necrotic pneumonia)Inflammation
05

Safety considerations

No direct therapeutics exist, but concerns include: strong tissue necrosis, severe inflammation, and risk of exacerbated sepsis or necrotizing pneumonia in PVL-positive *S. aureus* infections.Challenges include species-selectivity and the prospect of immune overreaction during therapeutic targeting
06

Biomarkers

Presence of lukS-PV and lukF-PV genes in *S. aureus* diagnostic panels is used as a molecular biomarker of PVL-positive, high-virulence *S. aureus* strains

Beyond the preview

Go deeper on Leukocidin S subunit of Panton–Valentine leukocidin (LukS-PV).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Leukocidin S subunit of Panton–Valentine leukocidin (LukS-PV).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call